Skip to main content
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1997 May;150(5):1773–1784.

Mediators of ischemia-reperfusion injury of rat lung.

M J Eppinger 1, G M Deeb 1, S F Bolling 1, P A Ward 1
PMCID: PMC1858208  PMID: 9137100

Abstract

In rats, we characterized the mediators of lung reperfusion injury after ischemia. Animals underwent left lung ischemia. After 90 minutes of ischemia, reperfusion for up to 4 hours was evaluated. Lung injury, as determined by vascular leakage of serum albumin, increased in ischemic-reperfused animals when compared with time-matched sham controls. Injury was biphasic, peaking at 30 minutes and 4 hours of reperfusion. The late but not the early phase of reperfusion injury is known to be neutrophil dependent. Bronchoalveolar lavage of ischemic-reperfused lungs at 30 minutes and 4 hours of reperfusion demonstrated increased presence of serum albumin, indicative of damage to the normal vascular/airway barrier. Lung mRNA for rat monocyte chemoattractant protein-1 and tumor necrosis factor-alpha peaked very early (between 0.5 and 1.0 hour) during the reperfusion process. Development of injury was associated with a decline in serum complement activity and progressive intrapulmonary sequestration of neutrophils. Administration of superoxide dismutase before reperfusion resulted in reduction of injury at 30 minutes of reperfusion. Complement depletion decreased injury at both 30 minutes and 4 hours of reperfusion. Requirements for tumor necrosis factor-alpha, interferon-gamma, and monocyte chemoattractant protein-1 for early injury were shown whereas only tumor necrosis factor-alpha was involved at 4 hours. We propose that acute (30-minute) lung injury is determined in large part by products of activated lung macrophages whereas the delayed (4-hour) injury is mediated by products of activated and recruited neutrophils.

Full text

PDF
1773

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arenzana-Seisdedos F., Virelizier J. L., Fiers W. Interferons as macrophage-activating factors. III. Preferential effects of interferon-gamma on the interleukin 1 secretory potential of fresh or aged human monocytes. J Immunol. 1985 Apr;134(4):2444–2448. [PubMed] [Google Scholar]
  2. Beckman J. S., Beckman T. W., Chen J., Marshall P. A., Freeman B. A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A. 1990 Feb;87(4):1620–1624. doi: 10.1073/pnas.87.4.1620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bradley P. P., Priebat D. A., Christensen R. D., Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982 Mar;78(3):206–209. doi: 10.1111/1523-1747.ep12506462. [DOI] [PubMed] [Google Scholar]
  4. Caty M. G., Guice K. S., Oldham K. T., Remick D. G., Kunkel S. I. Evidence for tumor necrosis factor-induced pulmonary microvascular injury after intestinal ischemia-reperfusion injury. Ann Surg. 1990 Dec;212(6):694–700. doi: 10.1097/00000658-199012000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Colletti L. M., Burtch G. D., Remick D. G., Kunkel S. L., Strieter R. M., Guice K. S., Oldham K. T., Campbell D. A., Jr The production of tumor necrosis factor alpha and the development of a pulmonary capillary injury following hepatic ischemia/reperfusion. Transplantation. 1990 Feb;49(2):268–272. doi: 10.1097/00007890-199002000-00008. [DOI] [PubMed] [Google Scholar]
  6. Colletti L. M., Remick D. G., Burtch G. D., Kunkel S. L., Strieter R. M., Campbell D. A., Jr Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest. 1990 Jun;85(6):1936–1943. doi: 10.1172/JCI114656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Craddock P. R., Fehr J., Dalmasso A. P., Brighan K. L., Jacob H. S. Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest. 1977 May;59(5):879–888. doi: 10.1172/JCI108710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Crawford M. H., Grover F. L., Kolb W. P., McMahan C. A., O'Rourke R. A., McManus L. M., Pinckard R. N. Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury. Circulation. 1988 Dec;78(6):1449–1458. doi: 10.1161/01.cir.78.6.1449. [DOI] [PubMed] [Google Scholar]
  9. Dierich M. P., Erdei A., Huemer H., Petzer A., Stauder R., Schulz T. F., Gergely J. Involvement of complement in B-cell, T-cell and monocyte/macrophage activation. Immunol Lett. 1987 Feb;14(3):235–242. doi: 10.1016/0165-2478(87)90107-6. [DOI] [PubMed] [Google Scholar]
  10. Eden E., Turino G. M. Interleukin-1 secretion by human alveolar macrophages stimulated with endotoxin is augmented by recombinant immune (gamma) interferon. Am Rev Respir Dis. 1986 Mar;133(3):455–460. doi: 10.1164/arrd.1986.133.3.455. [DOI] [PubMed] [Google Scholar]
  11. Eppinger M. J., Jones M. L., Deeb G. M., Bolling S. F., Ward P. A. Pattern of injury and the role of neutrophils in reperfusion injury of rat lung. J Surg Res. 1995 Jun;58(6):713–718. doi: 10.1006/jsre.1995.1112. [DOI] [PubMed] [Google Scholar]
  12. Eppinger M. J., Ward P. A., Jones M. L., Bolling S. F., Deeb G. M. Disparate effects of nitric oxide on lung ischemia-reperfusion injury. Ann Thorac Surg. 1995 Nov;60(5):1169–1176. doi: 10.1016/0003-4975(95)00697-J. [DOI] [PubMed] [Google Scholar]
  13. Gibbs L. S., Lai L., Malik A. B. Tumor necrosis factor enhances the neutrophil-dependent increase in endothelial permeability. J Cell Physiol. 1990 Dec;145(3):496–500. doi: 10.1002/jcp.1041450315. [DOI] [PubMed] [Google Scholar]
  14. Hammerschmidt D. E., Stroncek D. F., Bowers T. K., Lammi-Keefe C. J., Kurth D. M., Ozalins A., Nicoloff D. M., Lillehei R. C., Craddock P. R., Jacob H. S. Complement activation and neutropenia occurring during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1981 Mar;81(3):370–377. [PubMed] [Google Scholar]
  15. Hill J. H., Ward P. A. The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats. J Exp Med. 1971 Apr 1;133(4):885–900. doi: 10.1084/jem.133.4.885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hill J., Lindsay T. F., Ortiz F., Yeh C. G., Hechtman H. B., Moore F. D., Jr Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat. J Immunol. 1992 Sep 1;149(5):1723–1728. [PubMed] [Google Scholar]
  17. Horgan M. J., Lum H., Malik A. B. Pulmonary edema after pulmonary artery occlusion and reperfusion. Am Rev Respir Dis. 1989 Nov;140(5):1421–1428. doi: 10.1164/ajrccm/140.5.1421. [DOI] [PubMed] [Google Scholar]
  18. Issekutz A. C., Issekutz T. B. Quantitation and kinetics of blood monocyte migration to acute inflammatory reactions, and IL-1 alpha, tumor necrosis factor-alpha, and IFN-gamma. J Immunol. 1993 Aug 15;151(4):2105–2115. [PubMed] [Google Scholar]
  19. Jones M. L., Mulligan M. S., Flory C. M., Ward P. A., Warren J. S. Potential role of monocyte chemoattractant protein 1/JE in monocyte/macrophage-dependent IgA immune complex alveolitis in the rat. J Immunol. 1992 Sep 15;149(6):2147–2154. [PubMed] [Google Scholar]
  20. Klebanoff S. J., Vadas M. A., Harlan J. M., Sparks L. H., Gamble J. R., Agosti J. M., Waltersdorph A. M. Stimulation of neutrophils by tumor necrosis factor. J Immunol. 1986 Jun 1;136(11):4220–4225. [PubMed] [Google Scholar]
  21. Lindsay T. F., Hill J., Ortiz F., Rudolph A., Valeri C. R., Hechtman H. B., Moore F. D., Jr Blockade of complement activation prevents local and pulmonary albumin leak after lower torso ischemia-reperfusion. Ann Surg. 1992 Dec;216(6):677–683. doi: 10.1097/00000658-199212000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Livingston D. H., Appel S. H., Sonnenfeld G., Malangoni M. A. The effect of tumor necrosis factor-alpha and interferon-gamma on neutrophil function. J Surg Res. 1989 Apr;46(4):322–326. doi: 10.1016/0022-4804(89)90195-9. [DOI] [PubMed] [Google Scholar]
  23. Maroko P. R., Carpenter C. B., Chiariello M., Fishbein M. C., Radvany P., Knostman J. D., Hale S. L. Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion. J Clin Invest. 1978 Mar;61(3):661–670. doi: 10.1172/JCI108978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Marucha P. T., Zeff R. A., Kreutzer D. L. Cytokine-induced IL-1 beta gene expression in the human polymorphonuclear leukocyte: transcriptional and post-transcriptional regulation by tumor necrosis factor and IL-1. J Immunol. 1991 Oct 15;147(8):2603–2608. [PubMed] [Google Scholar]
  25. Mayer A. M., Pittner R. A., Lipscomb G. E., Spitzer J. A. Effect of in vivo TNF administration on superoxide production and PKC activity of rat alveolar macrophages. Am J Physiol. 1993 Jan;264(1 Pt 1):L43–L52. doi: 10.1152/ajplung.1993.264.1.L43. [DOI] [PubMed] [Google Scholar]
  26. McCord J. M. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med. 1985 Jan 17;312(3):159–163. doi: 10.1056/NEJM198501173120305. [DOI] [PubMed] [Google Scholar]
  27. Nathan C. F., Murray H. W., Wiebe M. E., Rubin B. Y. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med. 1983 Sep 1;158(3):670–689. doi: 10.1084/jem.158.3.670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Palace G. P., Del Vecchio P. J., Horgan M. J., Malik A. B. Release of tumor necrosis factor after pulmonary artery occlusion and reperfusion. Am Rev Respir Dis. 1993 Jan;147(1):143–147. doi: 10.1164/ajrccm/147.1.143. [DOI] [PubMed] [Google Scholar]
  29. Pham S. M., Yoshida Y., Aeba R., Hattler B. G., Iwaki Y., Zeevi A., Hardesty R. L., Griffith B. P. Interleukin-6, a marker of preservation injury in clinical lung transplantation. J Heart Lung Transplant. 1992 Nov-Dec;11(6):1017–1024. [PubMed] [Google Scholar]
  30. Phillips W. A., Croatto M., Hamilton J. A. Priming the macrophage respiratory burst with IL-4: enhancement with TNF-alpha but inhibition by IFN-gamma. Immunology. 1990 Aug;70(4):498–503. [PMC free article] [PubMed] [Google Scholar]
  31. Robbins R. A., Gossman G. L., Allington L. A., Kendall T. J., Stull T. W., Rennard S. I. Modulation of alveolar macrophage leukotriene B4 released by complement component C5. J Lab Clin Med. 1990 Apr;115(4):497–503. [PubMed] [Google Scholar]
  32. Rollins B. J., Walz A., Baggiolini M. Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes. Blood. 1991 Aug 15;78(4):1112–1116. [PubMed] [Google Scholar]
  33. Schmeling D. J., Caty M. G., Oldham K. T., Guice K. S., Hinshaw D. B. Evidence for neutrophil-related acute lung injury after intestinal ischemia-reperfusion. Surgery. 1989 Aug;106(2):195–202. [PubMed] [Google Scholar]
  34. Schorlemmer H. U. The role of complement in the function of the monocyte - macrophage system. Haematol Blood Transfus. 1981;27:59–71. doi: 10.1007/978-3-642-81696-3_7. [DOI] [PubMed] [Google Scholar]
  35. Seekamp A., Mulligan M. S., Till G. O., Ward P. A. Requirements for neutrophil products and L-arginine in ischemia-reperfusion injury. Am J Pathol. 1993 Apr;142(4):1217–1226. [PMC free article] [PubMed] [Google Scholar]
  36. Sekido N., Mukaida N., Harada A., Nakanishi I., Watanabe Y., Matsushima K. Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature. 1993 Oct 14;365(6447):654–657. doi: 10.1038/365654a0. [DOI] [PubMed] [Google Scholar]
  37. Shalaby M. R., Palladino M. A., Jr, Hirabayashi S. E., Eessalu T. E., Lewis G. D., Shepard H. M., Aggarwal B. B. Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha. J Leukoc Biol. 1987 Mar;41(3):196–204. doi: 10.1002/jlb.41.3.196. [DOI] [PubMed] [Google Scholar]
  38. Simpson R., Alon R., Kobzik L., Valeri C. R., Shepro D., Hechtman H. B. Neutrophil and nonneutrophil-mediated injury in intestinal ischemia-reperfusion. Ann Surg. 1993 Oct;218(4):444–454. doi: 10.1097/00000658-199310000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Svedersky L. P., Benton C. V., Berger W. H., Rinderknecht E., Harkins R. N., Palladino M. A. Biological and antigenic similarities of murine interferon-gamma and macrophage-activating factor. J Exp Med. 1984 Mar 1;159(3):812–827. doi: 10.1084/jem.159.3.812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Sztein M. B., Steeg P. S., Johnson H. M., Oppenheim J. J. Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons. J Clin Invest. 1984 Feb;73(2):556–565. doi: 10.1172/JCI111243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Till G. O., Johnson K. J., Kunkel R., Ward P. A. Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites. J Clin Invest. 1982 May;69(5):1126–1135. doi: 10.1172/JCI110548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Till G. O., Ward P. A. Systemic complement activation and acute lung injury. Fed Proc. 1986 Jan;45(1):13–18. [PubMed] [Google Scholar]
  43. Ulich T. R., Guo K., Yin S., del Castillo J., Yi E. S., Thompson R. C., Eisenberg S. P. Endotoxin-induced cytokine gene expression in vivo. IV. Expression of interleukin-1 alpha/beta and interleukin-1 receptor antagonist mRNA during endotoxemia and during endotoxin-initiated local acute inflammation. Am J Pathol. 1992 Jul;141(1):61–68. [PMC free article] [PubMed] [Google Scholar]
  44. Virelizier J. L., Perez N., Arenzana-Seisdedos F., Devos R. Pure interferon gamma enhances class II HLA antigens on human monocyte cell lines. Eur J Immunol. 1984 Jan;14(1):106–108. doi: 10.1002/eji.1830140120. [DOI] [PubMed] [Google Scholar]
  45. Wickersham N. E., Loyd J. E., Johnson J. E., McCain R. W., Christman J. W. Acute inflammation in a sheep model of unilateral lung ischemia: the role of interleukin-8 recruitment of polymorphonuclear leukocytes. Am J Respir Cell Mol Biol. 1993 Aug;9(2):199–204. doi: 10.1165/ajrcmb/9.2.199. [DOI] [PubMed] [Google Scholar]
  46. Yamashita C., Oobo H., Tsuji F., Tobe S., Yamamoto H., Nakamura H., Okada M., Nakamura K. Effect of prostaglandin I2 and superoxide dismutase on reperfusion injury of warm ischemic lung. Ann Thorac Surg. 1992 Nov;54(5):921–924. doi: 10.1016/0003-4975(92)90650-s. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES